Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
117.17 USD | -0.05% | +1.13% | +7.48% |
09-20 | Merck Receives Positive EU CHMP Opinions for Keytruda in Gynecologic Cancers | MT |
09-20 | Merck Gets European Panel Backing for Keytruda in Two Gynecologic Cancers | DJ |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Top Midday Stories: June US Job Openings Drop; Merck Cuts 2024 Non-GAAP EPS Forecast; Pfizer Adjusted Earnings Fall; Procter & Gamble Net Sales Decline; S&P Global Reports Higher Results, Lifts Fiscal 2024 Outlook; BP Underlying Earnings Gain; Meta Platforms to Pay $1.4 Billion to Settle Texas Facial Recognition Data Suit